[Current incidence and clinical significance of non-culturable bacilli or those culturable with difficulty]. 1978

V Golli, and I Stefănescu, and E Stefanin, and P Zaharia, and N Ionescu

An analysis of 246 patients with positive smear present bacilli and negative cultures revealed that in only 9% of the cases no organized previous treatment had been applied, although almost half of these had benefited from short courses with streptomycin associated with penicillin before an exact diagnosis of tuberculosis had been made. Since the remaining 91% had had 1--2 months of chemotherapy, which frequently included rifampicin, the authors stress that microscopically detectable germs are frequently incapable to develop on culture media. These are frequently non-viable bacteria and in such conditions no subsequent modifications of the currently applied therapy scheme should be attempted. The authors show that only 26,2% of the germs from 519 positive cultures have developed after 21 days from the seeding. At 30 days the overall proportion increased to 71,2% while at 45 days 22,7% more positive cultures appeared and an additional 6,1% cultures became positive at 60 days. Tubercle bacilli become increasingly demanding and slower growing. If at 21 days only one colony was evident in 6% of the cases, while an infinite number of colonies were present in 58% of the cultures at 60 days a single colony was found in 42% of the cases, in contrast with only 9% cases with an infinite number of colonies (P less than 0,001). The delay in the growth of bacilli was parallel with the duration of chemotherapy. The results are compared with data from the literature.

UI MeSH Term Description Entries
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D001431 Bacteriological Techniques Techniques used in studying bacteria. Bacteriologic Technic,Bacteriologic Technics,Bacteriologic Techniques,Bacteriological Technique,Technic, Bacteriological,Technics, Bacteriological,Technique, Bacteriological,Techniques, Bacteriological,Bacteriologic Technique,Bacteriological Technic,Bacteriological Technics,Technic, Bacteriologic,Technics, Bacteriologic,Technique, Bacteriologic,Techniques, Bacteriologic
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

V Golli, and I Stefănescu, and E Stefanin, and P Zaharia, and N Ionescu
January 1977, Revista de igiena, bacteriologie, virusologie, parazitologie, epidemiologie, pneumoftiziologie. Pneumoftiziologia,
V Golli, and I Stefănescu, and E Stefanin, and P Zaharia, and N Ionescu
September 1975, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
V Golli, and I Stefănescu, and E Stefanin, and P Zaharia, and N Ionescu
May 1955, Postgraduate medicine,
V Golli, and I Stefănescu, and E Stefanin, and P Zaharia, and N Ionescu
April 1997, Enfermedades infecciosas y microbiologia clinica,
V Golli, and I Stefănescu, and E Stefanin, and P Zaharia, and N Ionescu
January 1966, Polish medical journal,
V Golli, and I Stefănescu, and E Stefanin, and P Zaharia, and N Ionescu
February 1966, Archivio di tisiologia e delle malattie dell'apparato respiratorio,
V Golli, and I Stefănescu, and E Stefanin, and P Zaharia, and N Ionescu
July 1962, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society,
V Golli, and I Stefănescu, and E Stefanin, and P Zaharia, and N Ionescu
July 2010, The Science of the total environment,
V Golli, and I Stefănescu, and E Stefanin, and P Zaharia, and N Ionescu
November 1987, Bulletin de l'Academie nationale de medecine,
V Golli, and I Stefănescu, and E Stefanin, and P Zaharia, and N Ionescu
July 2021, Microorganisms,
Copied contents to your clipboard!